1. Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin. 1992. 02. 10(1):87–111.
Article
2. Bar-Sela S, Ehrenfeld M, Eliakim M. Arterial embolism in thyrotoxicosis with atrial fibrillation. Arch Intern Med. 1981. 08. 141(9):1191–1192.
Article
3. Chang DC, Wheeler MH, Woodcock JP, Curley I, Lazarus JR, Fung H, et al. The effect of preoperative Lugol's iodine on thyroid blood flow in patients with Graves' hyperthyroidism. Surgery. 1987. 12. 102(6):1055–1061.
4. Dai A, Wasay M, Dubey N, Giglio P, Bakshi R. Superior sagittal sinus thrombosis secondary to hyperthyroidism. J Stroke Cerebrovasc Dis. 2000. Mar-Apr. 9(2):89–90.
Article
5. de Bruijn SF, de Haan RJ, Stam J. For the Cerebral Venous Sinus Thrombosis Study Group. Clinical features and prognostic factors of cerebral venous thrombosis in a prospective series of 59 patients. J Neurol Neurosurg Psychiatry. 2001. 01. 70(1):105–108.
6. Egeberg O. Influence of thyroid function on the blood clotting system. Scand J Clin Lab Invest. 1963. 15(1):1–7.
Article
7. Einhäupl K, Bousser MG, de Bruijn SF, Ferro JM, Martinelli I, Masuhr F, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol. 2006. 06. 13(6):553–559.
Article
8. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F. ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004. 03. 35(3):664–667.
9. Farid NR, Griffiths BL, Collins JR, Marshall WH, Ingram DW. Blood coagulation and fibrinolysis in thyroid disease. Thromb Haemost. 1976. 04. 35(2):415–422.
Article
10. Hodgson KJ, Lazarus JH, Wheeler MH, Woodcock JP, Owen GM, McGregor AM, et al. Duplex scan-derived thyroid blood flow in euthyroid and hyperthyroid patients. World J Surg. 1988. 08. 12(4):470–475.
Article
11. Hurley DM, Hunter AN, Hewett MJ, Stockigt JR. Atrial fibrillation and arterial embolism in hyperthyroidism. Aust N Z J Med. 1981. 08. 11(4):391–393.
Article
12. Meijers JC, Tekelenburg WL, Bouma BN, Bertina RM, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med. 2000. 03. 342(10):696–701.
Article
13. Petersen P, Hansen JM. Stroke in thyrotoxicosis with atrial fibrillation. Stroke. 1988. 01. 19(1):15–18.
Article
14. Prentice CRM, Forbes CD, Smith SM. Rise of factor VIII activity after exercise and adrenaline infusion, measured by immunological and biological techniques. Thromb Res. 1972. 10. 1(5):493–505.
15. Rogers JS 2nd, Shane SR, Jencks FS. Factor VIII activity and thyroid function. Ann Intern Med. 1982. 11. 97(5):713–716.
Article
16. Schutta HS, Williams EC, Baranski BG, Sutula TP. Cerebral venous thrombosis with plasminogen deficiency. Stroke. 1991. 03. 22(3):401–405.
Article
17. Siegert CE, Smelt AH, de Bruin TW. Superior sagittal thrombosis and thyrotoxicosis. Possible association in two cases. Stroke. 1995. 03. 26(3):496–497.
18. Simone JV, Abildgaard CF, Schulman I. Blood coagulation in thyroid dysfunction. N Engl J Med. 1965. 11. 273(20):1057–1061.
Article
19. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005. 04. 352(17):1791–1798.
Article
20. van Hylckama Vlieg A, van der Linden IK, Bertina RM, Rosendaal FR. High levels of factor XI increase the risk of venous thrombosis. Blood. 2000. 06. 95(12):3678–3682.